Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiarrhythmic therapy in elderly persons: a device-based approach.

Kevin J Ferrick1

  • 1Arrhythmia Service, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467-2401, USA. kferrick@montefiore.org

The American Journal of Geriatric Cardiology
|January 18, 2005
PubMed
Summary

Device-based therapy is increasingly effective for managing ventricular arrhythmias in elderly patients, offering superior protection independent of age. Technological advances make these treatments safer and more accessible for older individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multisite, External Validation of an AI-Enabled ECG Algorithm for Detection of Low Ejection Fraction.

JACC. Advances·2026
Same author

Very late interventricular septal perforation of a left bundle branch area pacing lead associated with multifocal stroke.

Heart rhythm·2025
Same author

A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia.

Cardio-oncology (London, England)·2024
Same author

Predictors of paroxysmal atrial fibrillation in patients with a cryptogenic stroke: Selecting patients for long-term rhythm monitoring.

Heart rhythm·2024
Same author

Premature ventricular complexes: Assessing burden density in a large national cohort to better define optimal ECG monitoring duration.

Heart rhythm·2024
Same author

Utilization of the remote monitoring of cardiac implantable electronic devices in a diverse demographic cohort: Insights from a single-center observation.

Pacing and clinical electrophysiology : PACE·2023

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Biomedical Engineering

Background:

  • Elderly patients present unique pharmacokinetic and pharmacodynamic challenges for traditional antiarrhythmic drug therapy.
  • Altered drug metabolism in older adults narrows the therapeutic window for managing ventricular arrhythmias.
  • Device-based therapies offer a non-pharmacologic alternative, unaffected by metabolic changes.

Purpose of the Study:

  • To review the evolving management strategies for ventricular arrhythmias in the elderly population.
  • To evaluate the efficacy and safety of device-based therapy compared to pharmacologic agents in older adults.
  • To highlight recent technological advancements in device therapy for malignant ventricular arrhythmias.

Main Methods:

  • Review of recent studies and technological advancements in device-based therapy for ventricular arrhythmias.

Related Experiment Videos

  • Analysis of pharmacokinetic and pharmacodynamic considerations in elderly patients.
  • Comparison of outcomes between pharmacologic and device-based therapies in elderly populations.

    • Main Results:

    • Device-based therapy shows superior protection against malignant ventricular arrhythmias for both primary and secondary prevention in elderly patients.
    • The benefits of device-based therapy are observed irrespective of patient age.
    • Complication rates associated with device-based therapy are also independent of age.

    Conclusions:

    • Device-based therapy is a highly effective and safe option for managing ventricular arrhythmias in elderly individuals.
    • Technological progress has made device therapy a more attractive and viable choice for this demographic.
    • Age is not a barrier to the successful implementation and benefits of device-based arrhythmia management.